These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 893736)

  • 1. Pharmacokinetics and hepatic extraction ratio of pindolol in hypertensive patients with normal and impaired renal function.
    Lavene D; Weiss YA; Safar ME; Loria Y; Agorus N; Georges D; Milliez PL
    J Clin Pharmacol; 1977; 17(8-9):501-8. PubMed ID: 893736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intravenous and oral pindolol in hypertensive patients with chronic renal failure.
    Safar ME; Chau NP; Levenson JA; Simon AC; Weiss YA
    Clin Sci Mol Med Suppl; 1978 Dec; 4():275s-277s. PubMed ID: 282067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pindolol availability in hypertensive patients with normal and impaired renal function.
    Chau NP; Weiss YA; Safar ME; Lavene DE; Georges DR; Milliez PL
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):505-10. PubMed ID: 913016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of unchanged pindolol in patients with impaired renal function.
    Ohnhaus EE
    Br J Pharmacol; 1973 Mar; 47(3):620P-621P. PubMed ID: 4730841
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal function during acute and long term pindolol treatment in hypertensive patients with normal and decreased glomerular filtration.
    Rosenfeld J; Boner G; Wainer E
    Br J Clin Pharmacol; 1982; 13(Suppl 2):237S-240S. PubMed ID: 7104147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of pindolol in liver disease.
    Ohnhaus EE; Münch U; Meier J
    Eur J Clin Pharmacol; 1982; 22(3):247-51. PubMed ID: 7106158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biased estimates of nonrenal clearance.
    Hinderling PH
    J Pharm Sci; 2001 Jul; 90(7):960-6. PubMed ID: 11458343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pindolol on renal function II. Effects on intravenous and prolonged oral dosing.
    Boner G; Wainer E; Rosenfeld JB
    Clin Pharmacol Ther; 1982 Oct; 32(4):423-7. PubMed ID: 7116756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of bioavailability and pharmacokinetics of cimetidine in subjects with normal and impaired renal function.
    Guay DR; Matzke GR; Bockbrader HN; Dancik J
    Clin Pharm; 1983; 2(2):157-62. PubMed ID: 6883944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of guanfacine in patients with impaired renal function and in some elderly patients.
    Kiechel JR
    Am J Cardiol; 1986 Mar; 57(9):18E-21E. PubMed ID: 3513525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.
    Huet PM; Lelorier J
    Clin Pharmacol Ther; 1980 Aug; 28(2):208-15. PubMed ID: 7398188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between renal function and elimination kinetics of pindolol in man.
    Oie S; Levy G
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):115-6. PubMed ID: 1233259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metoclopramide kinetics in patients with impaired renal function and clearance by hemodialysis.
    Lehmann CR; Heironimus JD; Collins CB; O'Neil TJ; Pierson WP; Crowe JT; Melikian AP; Wright GJ
    Clin Pharmacol Ther; 1985 Mar; 37(3):284-9. PubMed ID: 3971652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients.
    Rouan MC; Binswanger U; Bammatter F; Theobald W; Schoeller JP; Guibert J
    J Antimicrob Chemother; 1984 Jun; 13(6):611-8. PubMed ID: 6088464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective renal clearance of pindolol in humans.
    Hsyu PH; Giacomini KM
    J Clin Invest; 1985 Nov; 76(5):1720-6. PubMed ID: 4056049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal disease and drug metabolism: an overview.
    Gibson TP
    Am J Kidney Dis; 1986 Jul; 8(1):7-17. PubMed ID: 3524205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of fosinopril in patients with various degrees of renal function.
    Hui KK; Duchin KL; Kripalani KJ; Chan D; Kramer PK; Yanagawa N
    Clin Pharmacol Ther; 1991 Apr; 49(4):457-67. PubMed ID: 1826651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cimetidine in advanced cirrhosis.
    Grahnén A; Jameson S; Lööf L; Tyllström J; Lindström B
    Eur J Clin Pharmacol; 1984; 26(3):347-55. PubMed ID: 6734697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of renal insufficiency on the hepatic clearance of some drugs.
    Balant LP; Dayer P; Fabre J
    Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency.
    Gehr TW; Rudy DW; Matzke GR; Kramer WG; Sica DA; Brater DC
    Clin Pharmacol Ther; 1994 Jul; 56(1):31-8. PubMed ID: 8033492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.